Medicine composition for treating and preventing stomach and intestine tumor
A composition and tumor technology, applied in the field of medicine, can solve the problems of limited oncogene or tumor suppressor gene methylation or acetylation research, etc., and achieve the effects of low price, reducing toxic and side effects, and improving anti-tumor effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Colorectal cancer cell lines SW1116 and Colo-320 (purchased from Shanghai Institute of Cellular Science, Chinese Academy of Sciences) were routinely cultured in RPMI 1640 medium, and quantitative RT-PCR, sequencing after bisulfite modification or methylation-specific PCR (MSP) And Western blotting, chromatin immunoprecipitation (ChIP) to analyze the changes of related gene expression, DNA methylation and histone acetylation before and after intervention, and flow cytometry (FCM) to analyze the changes of cell cycle . NaBu (5mmol / L), 5-aza-dC (2μmol / L), and the pharmaceutical composition of the present invention (in which NaBu 5mmo / L, 5-aza-dC 2μmol / L) were intervened for 24 hours respectively. The control group was without any treatment. After synchronization treatment, the cell cycle was detected by flow cytometry, and the tumor suppressor gene p16 was detected by RT-PCR INK4A and p21 WAF1 mRNA expression, p16 analysis by co-immunoprecipitation INK4A and p21 WAF1 ...
Embodiment 2
[0034] The chemical carcinogen dimethylhydrazine (1,2-dimethylhydrazine, DMH) was used to induce colorectal cancer in ICR mice. The mice were female inbred S-ICR mice weighing 18-20 g (purchased from the Chinese Academy of Sciences in Shanghai). During the modeling period, NaBu, 5-aza-dC, 5-aza-dC and NaBu pharmaceutical compositions were used to intervene in the tumorigenesis process, and the pathological changes of the mouse intestine were analyzed.
[0035] Grouping of mice and drug intervention
[0036] 1) blank control group,
[0037] 2) NaBu control group,
[0038] 3) 5-aza-dC control group,
[0039] 4) drug combination control group,
[0040] 5) DMH control group,
[0041] 6) DMH+NaBu,
[0042] 7) DMH+5-aza-dC,
[0043] 8) DMH + the drug of the present invention (NaBu, 5-aza-dC).
[0044] About dosage and route of administration:
[0045] The carcinogen DMH is a white powder crystal, and it is made into a 0.4% solution with sterile normal saline before each inje...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap